Aemetis (NASDAQ:AMTX) Issues Quarterly Earnings Results

Aemetis (NASDAQ:AMTXGet Free Report) announced its quarterly earnings results on Tuesday. The specialty chemicals company reported ($0.38) EPS for the quarter, beating the consensus estimate of ($0.47) by $0.09, Zacks reports. The business had revenue of $81.44 million during the quarter, compared to analyst estimates of $77.79 million. During the same period last year, the company earned ($0.59) EPS.

Aemetis Stock Performance

Shares of Aemetis stock traded down $0.16 during trading hours on Thursday, reaching $3.97. 323,835 shares of the company were exchanged, compared to its average volume of 804,479. The firm has a market cap of $187.37 million, a PE ratio of -1.83 and a beta of 1.23. Aemetis has a 1 year low of $2.10 and a 1 year high of $7.03. The stock’s fifty day moving average is $2.73 and its 200 day moving average is $3.06.

Analyst Upgrades and Downgrades

Several brokerages have weighed in on AMTX. Truist Financial reaffirmed a “hold” rating and set a $3.50 target price (down previously from $4.00) on shares of Aemetis in a research note on Wednesday, July 31st. Ascendiant Capital Markets dropped their target price on shares of Aemetis from $20.00 to $19.00 and set a “buy” rating for the company in a report on Tuesday, September 3rd. HC Wainwright reissued a “buy” rating and issued a $28.00 target price on shares of Aemetis in a research report on Friday, August 2nd. StockNews.com upgraded Aemetis to a “sell” rating in a research report on Wednesday, July 31st. Finally, UBS Group cut their price objective on Aemetis from $8.25 to $7.75 and set a “buy” rating on the stock in a report on Monday, August 19th. One analyst has rated the stock with a sell rating, one has given a hold rating and four have given a buy rating to the company. Based on data from MarketBeat, the company currently has an average rating of “Moderate Buy” and an average price target of $12.95.

Check Out Our Latest Research Report on Aemetis

Aemetis Company Profile

(Get Free Report)

Aemetis, Inc operates as a renewable natural gas and renewable fuels company. It operates through three segments: California Ethanol, California Dairy Renewable Natural Gas, and India Biodiesel. The company focuses on the operation, acquisition, development, and commercialization of technologies to produce low and negative carbon intensity renewable fuels that replace fossil-based products.

Featured Stories

Earnings History for Aemetis (NASDAQ:AMTX)

Receive News & Ratings for Aemetis Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Aemetis and related companies with MarketBeat.com's FREE daily email newsletter.